FATE Price / Book | FATE THERAPEUTICS INC

FATE THERAPEUTICS INC (FATE) Price / Book

2026-09-03: Price/Book Ratio 1.89.
2026-06-30: Price/Book Ratio 2.05.
2026-03-31: Price/Book Ratio 0.78.
2025-12-31: Price/Book Ratio 0.55.

Historical market capitalization divided by filed shareholder equity.

Available history: 2013-12-31 to 2026-09-03
Data captured: 2026-09-04

Historical Price/Book Ratio

Date	Price/Book Ratio
2026-09-03	1.89
2026-06-30	2.05
2026-03-31	0.78
2025-12-31	0.55
2025-09-30	0.62
2025-06-30	0.49
2025-03-31	0.31
2024-12-31	0.59
2024-09-30	1.1
2024-06-30	0.94
2024-03-31	1.96
2023-12-31	1
2023-09-30	0.52
2023-06-30	1.07
2023-03-31	1.17
2022-12-31	2.03
2022-09-30	4.2
2022-06-30	4.13
2022-03-31	5.91
2021-12-31	8.25
2021-09-30	7.74
2021-06-30	10.88
2021-03-31	9.8
2020-12-31	20.75
2020-09-30	8.19
2020-06-30	6.28
2020-03-31	7.7
2019-12-31	6.06
2019-09-30	4.37
2019-06-30	10.4
2019-03-31	7.84
2018-12-31	5.17
2018-09-30	6.04
2018-06-30	11.68
2018-03-31	7.94
2017-12-31	4.17
2017-09-30	3.59
2017-06-30	2.43
2017-03-31	2.95
2016-12-31	1.42
2016-09-30	4.2
2016-06-30	2.12
2016-03-31	1.69
2015-12-31	2.54
2015-09-30	3.4
2015-06-30	3.63
2015-03-31	4.75
2014-12-31	3.65
2014-09-30	3.12
2014-06-30	3.27
2014-03-31	4.41
2013-12-31	2.52

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Liminatus Pharma, Inc. (LIMN)	United States	$0.282B
Lexeo Therapeutics, Inc. (LXEO)	United States	$0.278B	-4.19
PALISADE BIO, INC. (PALI)	United States	$0.275B	-11.41
Invivyd, Inc. (IVVD)	United States	$0.270B	-2.42
Inhibikase Therapeutics, Inc. (IKT)	United States	$0.296B	-4.44
X4 Pharmaceuticals, Inc (XFOR)	United States	$0.297B	-4.99
SUTRO BIOPHARMA, INC. (STRO)	United States	$0.260B	-3.05
SAB Biotherapeutics, Inc. (SABS)	United States	$0.306B	-25.49
Century Therapeutics, Inc. (IPSC)	United States	$0.306B	-4.02
Lineage Cell Therapeutics, Inc. (LCTX)	United States	$0.241B	-10.35